Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice (Q42517747)

1 November 2017

title

Amelioration of cisplatin-induced nephrotoxicity in peroxiredoxin I-deficient mice (English)

1 reference

1 November 2017

7

1 reference

1 November 2017

Kosuke Okada

1

1 reference

1 November 2017

Dongmei Ma

2

1 reference

1 November 2017

Eiji Warabi

3

1 reference

1 November 2017

Naoki Morito

4

1 reference

1 November 2017

Kentaro Akiyama

5

1 reference

1 November 2017

Yasuhiro Murata

6

1 reference

1 November 2017

Hiroki Bukawa

8

1 reference

1 November 2017

Junichi Shoda

9

1 reference

1 November 2017

Tetsuro Ishii

10

1 reference

1 November 2017

Toru Yanagawa

11

1 reference

1 November 2017

publication date

11 December 2012

1 reference

Cancer Chemotherapy and Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

71

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

503-509

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-012-2046-0

1 November 2017

exact match

0 references

cites work

Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Cisplatin nephrotoxicity. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Assessment of cisplatin-induced nephrotoxicity by microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

C-myc amplification altered the gene expression of ABC- and SLC-transporters in human breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Peroxiredoxin I plays a protective role against cisplatin cytotoxicity through mitogen activated kinase signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

Urinary marker for oxidative stress in kidneys in cisplatin-induced acute renal failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-012-2046-0

10.1007/S00280-012-2046-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1040681262

0 references

1 reference